PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
2,926,838
Share change
-156,787
Total reported value
$72,116,700
Price per share
$24.68
Number of holders
52
Value change
-$3,495,271
Number of buys
25
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q4 2016

As of 31 Dec 2016, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,926,838 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Moors & Cabot, Inc., Tieton Capital Management, LLC, Uniplan Investment Counsel, Inc., VANGUARD GROUP INC, CRAWFORD INVESTMENT COUNSEL INC, Wall Street Access Asset Management, LLC, Granite Investment Partners, LLC, DIMENSIONAL FUND ADVISORS LP, and RBF Capital, LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.